XFOR
X4 Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
XFOR fundamentals
X4 Pharmaceuticals (XFOR) released its earnings on Aug 8, 2025: revenue was 1.97M (YoY +250.44%), beat estimates; EPS was -3.47 (YoY -125.70%), beat estimates.
Revenue / YoY
1.97M
+250.44%
EPS / YoY
-3.47
-125.70%
Report date
Aug 8, 2025
Earnings
EPS
Revenue
Revenue & Expenses
XFOR has released its 2025 Q4 earnings report, with revenue of 2.57M, reflecting a YoY change of 79.08%, and net profit of -23.93M, showing a YoY change of 39.92%. The Sankey diagram below clearly presents XFOR's revenue sources and cost distribution.
Key Indicators
X4 Pharmaceuticals (XFOR) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
X4 Pharmaceuticals (XFOR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
X4 Pharmaceuticals (XFOR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
X4 Pharmaceuticals (XFOR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does X4 Pharmaceuticals (XFOR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track X4 Pharmaceuticals (XFOR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in X4 Pharmaceuticals's revenue and profit?What were the key takeaways from X4 Pharmaceuticals’s earnings call?What is the revenue and EPS growth rate for X4 Pharmaceuticals year over year?What is X4 Pharmaceuticals's gross profit margin?What were the key takeaways from X4 Pharmaceuticals's earnings call?What is X4 Pharmaceuticals's latest dividend and current dividend yield?Did X4 Pharmaceuticals beat or miss consensus estimates last quarter?What guidance did X4 Pharmaceuticals's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
